Variable Increased Expression of Program Death-1 and Program Death-1 Ligands on Peripheral Mononuclear Cells Is Not Impaired in Patients with Systemic Lupus Erythematosus

Figure 1

One representative FACS Dot-plot data of PD-1, PD-L1, and PD-L2 on CD3⁺ T cells (a), CD19⁺B cells (b), and CD14⁺ monocytes (c).

(a)

(b)

(c)